CDP870/Certolizumab Pegol
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CDP870/Certolizumab Pegol, covering 2020-08-03 to 2020-08-03. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease [Phase 2]